FLUANXOL 3MG - TAB TABLET

Country: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

FLUPENTIXOL (FLUPENTIXOL DIHYDROCHLORIDE)

থেকে পাওয়া:

LUNDBECK CANADA INC

এটিসি কোড:

N05AF01

INN (International Name):

FLUPENTIXOL

ডোজ:

3MG

ফার্মাসিউটিকাল ফর্ম:

TABLET

রচনা:

FLUPENTIXOL (FLUPENTIXOL DIHYDROCHLORIDE) 3MG

প্রশাসন রুট:

ORAL

প্যাকেজ ইউনিট:

100

প্রেসক্রিপশন টাইপ:

Prescription

Therapeutic area:

THIOXANTHENES

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0131297002; AHFS:

অনুমোদন অবস্থা:

MARKETED

অনুমোদন তারিখ:

1995-12-31

পণ্য বৈশিষ্ট্য

_ _
_ _
_Page 1 of 35 _
November 17, 2017
PRODUCT MONOGRAPH
Pr
FLUANXOL
®
Flupentixol Tablets
(as flupentixol dihydrochloride)
0.5 mg, 3 mg, and 5 mg
Pr
FLUANXOL
®
DEPOT
Flupentixol Decanoate Intramuscular Injection
2% and 10% flupentixol decanoate
ANTIPSYCHOTIC AGENT
Lundbeck Canada Inc.
2600 Alfred-Nobel
Suite 400
St-Laurent, QC
H4S 0A9
Date of Revision:
December 12, 2017
Submission Control No : 209135
_ _
_ _
_Page 2 of 35_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
..................................................................................................10
DRUG INTERACTIONS
..................................................................................................13
DOSAGE AND ADMINISTRATION
..............................................................................15
OVERDOSAGE
................................................................................................................18
ACTION AND CLINICAL PHARMACOLOGY
............................................................19
STORAGE AND STABILITY
..........................................................................................21
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................22
PART II: SCIENTIFIC INFORMATION
...............................................................................23
PHARMACEUTICAL INFORMATION
..........................................................................23
DETAILED PHARMACOLOGY
.................................................